Cargando…

The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease

BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PART...

Descripción completa

Detalles Bibliográficos
Autores principales: Mace-Brickman, Trevor, Eddeen, Anan Bader, Carrero, Juan-Jesus, Mark, Patrick B., Molnar, Amber O., Lam, Ngan N., Zimmerman, Deborah, Harel, Ziv, Sood, Manish M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893926/
https://www.ncbi.nlm.nih.gov/pubmed/31839975
http://dx.doi.org/10.1177/2054358119892372
_version_ 1783476300934021120
author Mace-Brickman, Trevor
Eddeen, Anan Bader
Carrero, Juan-Jesus
Mark, Patrick B.
Molnar, Amber O.
Lam, Ngan N.
Zimmerman, Deborah
Harel, Ziv
Sood, Manish M.
author_facet Mace-Brickman, Trevor
Eddeen, Anan Bader
Carrero, Juan-Jesus
Mark, Patrick B.
Molnar, Amber O.
Lam, Ngan N.
Zimmerman, Deborah
Harel, Ziv
Sood, Manish M.
author_sort Mace-Brickman, Trevor
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PARTICIPANTS: A total of 736 666 individuals (>40 years) from 2002 to 2015. MEASUREMENTS: New-onset AF, albumin-to-creatinine ratio (ACR), and an estimated glomerular filtration rate (eGFR). METHODS: A total of 39 120 matched patients were examined for the risk of ischemic, hemorrhagic, or any stroke event, accounting for the competing risk of all-cause mortality. Interaction terms for combinations of ACR/eGFR and the outcome of stroke with and without AF were examined. RESULTS: In a total of 4086 (5.2%) strokes (86% ischemic), the presence of AF was associated with a 2-fold higher risk for any stroke event and its subtypes of ischemic and hemorrhagic stroke. Across eGFR levels, the risk of stroke was 2-fold higher with the presence of AF except for low levels of eGFR (eGFR < 30 mL/min/1.73 m(2), hazard ratio [HR]: 1.38, 95% confidence interval [CI]: 0.99-1.92). Similarly across ACR levels, the risk of stroke was 2-fold higher except for high levels of albuminuria (ACR > 30 mg/g, HR: 1.61, 95% CI: 1.31-1.99). The adjusted risk of stroke with AF differed by combinations of ACR and eGFR categories (interaction P value = .04) compared with those without AF. Both stroke types were more common in patients with AF, and ischemic stroke rates differed significantly by eGFR and ACR categories. LIMITATIONS: Medication information was not included. CONCLUSIONS: Patients with CKD and AF are at a high risk of total, ischemic, and hemorrhagic strokes; the risk is highest with lower eGFR and higher ACR and differs based on eGFR and the degree of ACR.
format Online
Article
Text
id pubmed-6893926
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-68939262019-12-13 The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease Mace-Brickman, Trevor Eddeen, Anan Bader Carrero, Juan-Jesus Mark, Patrick B. Molnar, Amber O. Lam, Ngan N. Zimmerman, Deborah Harel, Ziv Sood, Manish M. Can J Kidney Health Dis Original Clinical Research BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are known to increase the risk of stroke. OBJECTIVES: We set out to examine the risk of stroke by kidney function and albuminuria in patients with and without AF. DESIGN: Retrospective cohort study. SETTINGS: Ontario, Canada. PARTICIPANTS: A total of 736 666 individuals (>40 years) from 2002 to 2015. MEASUREMENTS: New-onset AF, albumin-to-creatinine ratio (ACR), and an estimated glomerular filtration rate (eGFR). METHODS: A total of 39 120 matched patients were examined for the risk of ischemic, hemorrhagic, or any stroke event, accounting for the competing risk of all-cause mortality. Interaction terms for combinations of ACR/eGFR and the outcome of stroke with and without AF were examined. RESULTS: In a total of 4086 (5.2%) strokes (86% ischemic), the presence of AF was associated with a 2-fold higher risk for any stroke event and its subtypes of ischemic and hemorrhagic stroke. Across eGFR levels, the risk of stroke was 2-fold higher with the presence of AF except for low levels of eGFR (eGFR < 30 mL/min/1.73 m(2), hazard ratio [HR]: 1.38, 95% confidence interval [CI]: 0.99-1.92). Similarly across ACR levels, the risk of stroke was 2-fold higher except for high levels of albuminuria (ACR > 30 mg/g, HR: 1.61, 95% CI: 1.31-1.99). The adjusted risk of stroke with AF differed by combinations of ACR and eGFR categories (interaction P value = .04) compared with those without AF. Both stroke types were more common in patients with AF, and ischemic stroke rates differed significantly by eGFR and ACR categories. LIMITATIONS: Medication information was not included. CONCLUSIONS: Patients with CKD and AF are at a high risk of total, ischemic, and hemorrhagic strokes; the risk is highest with lower eGFR and higher ACR and differs based on eGFR and the degree of ACR. SAGE Publications 2019-12-04 /pmc/articles/PMC6893926/ /pubmed/31839975 http://dx.doi.org/10.1177/2054358119892372 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Clinical Research
Mace-Brickman, Trevor
Eddeen, Anan Bader
Carrero, Juan-Jesus
Mark, Patrick B.
Molnar, Amber O.
Lam, Ngan N.
Zimmerman, Deborah
Harel, Ziv
Sood, Manish M.
The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title_full The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title_fullStr The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title_full_unstemmed The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title_short The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
title_sort risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease
topic Original Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893926/
https://www.ncbi.nlm.nih.gov/pubmed/31839975
http://dx.doi.org/10.1177/2054358119892372
work_keys_str_mv AT macebrickmantrevor theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT eddeenananbader theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT carrerojuanjesus theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT markpatrickb theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT molnarambero theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT lamngann theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT zimmermandeborah theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT harelziv theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT soodmanishm theriskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT macebrickmantrevor riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT eddeenananbader riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT carrerojuanjesus riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT markpatrickb riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT molnarambero riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT lamngann riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT zimmermandeborah riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT harelziv riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease
AT soodmanishm riskofstrokeandstroketypeinpatientswithatrialfibrillationandchronickidneydisease